BOSTON, Aug. 11, 2017 /PRNewswire/ -- Orig3n Inc., a Boston-based biotech company pioneering the future of medicine through genetics and regenerative medicine research, announced a partnership today with the Baltimore Ravens. As part of a multi-year agreement, Orig3n will play a featured role in enhancing the fan experience at home games. The Ravens join the San Francisco 49ers in the growing roster of professional sports teams who recognize the cutting-edge and unique community opportunities a partnership with Orig3n offers. (PRNewsfoto/ORIG3N, Inc.)More